TREM1
Triggering receptor expressed on myeloid cells 1
Also known as: CD354, TREM-1, TREM1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NP99
- Gene
- TREM1
- Ensembl
- ENSG00000124731
- Chromosome
- 6
- Canonical length
- 234 aa
- Protein class
- CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins
- Subcellular location
- Golgi apparatus
- Secretome location
- Secreted to blood
- Quaternary structure
- Homomultimer
OverviewNCBI Gene
This gene encodes a receptor belonging to the Ig superfamily that is expressed on myeloid cells. This protein amplifies neutrophil and monocyte-mediated inflammatory responses triggered by bacterial and fungal infections by stimulating release of pro-inflammatory chemokines and cytokines, as well as increased surface expression of cell activation markers. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene.[provided by RefSeq, Jun 2011]
Canonical amino-acid sequenceUniProt
234 residues, UniProt reviewed canonical sequence.
>Q9NP99|TREM1
1 MRKTRLWGLL WMLFVSELRA ATKLTEEKYE LKEGQTLDVK CDYTLEKFAS SQKAWQIIRD
61 GEMPKTLACT ERPSKNSHPV QVGRIILEDY HDHGLLRVRM VNLQVEDSGL YQCVIYQPPK
121 EPHMLFDRIR LVVTKGFSGT PGSNENSTQN VYKIPPTTTK ALCPLYTSPR TVTQAPPKST
181 ADVSTPDSEI NLTNVTDIIR VPVFNIVILL AGGFLSKSLV FSVLFAVTLR SFVPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TREM1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 91 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 91 nTPM
- lung: 62 nTPM
- appendix: 42 nTPM
- adipose tissue: 19 nTPM
- choroid plexus: 12 nTPM
- urinary bladder: 12 nTPM
Single-cell type
- neutrophils: 1,521 nCPM
- monocytes: 187 nCPM
- macrophages: 54 nCPM
- neutrophil progenitors: 49 nCPM
- monocyte progenitors: 45 nCPM
- late spermatids: 45 nCPM
Immune cell
- neutrophil: 617 nTPM
- classical monocyte: 83 nTPM
- myeloid DC: 33 nTPM
- total PBMC: 32 nTPM
- intermediate monocyte: 21 nTPM
- non-classical monocyte: 10 nTPM
Brain region
- cerebral cortex: 16 nTPM
- thalamus: 5 nTPM
- choroid plexus: 3.9 nTPM
- pons: 3.4 nTPM
- medulla oblongata: 1.5 nTPM
- white matter: 1.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.02
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.08
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adaptive immune response
- humoral immune response
- immune response
- innate immune response
- intracellular signal transduction
- neutrophil chemotaxis
- neutrophil-mediated killing of gram-negative bacterium
Molecular functions
- receptor decoy activity
- scaffold protein binding
- signaling receptor activity
- transmembrane signaling receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TREM1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TREM1 as an antibody target. Whether an autoantibody or antibody against TREM1 could matter depends on whether native TREM1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TREM1 is annotated at the cell surface, where native TREM1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TREM1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...